Chris Viehbacher

Chris Viehbacher (born 1960) is a German-Canadian businessman.[1][2][3][4] He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014.[2][3][4] Viehbacher is currently Managing Partner of Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.[5][6]

Early life

Chris Viehbacher was born on March 26, 1960.[4] He graduated from Queen's University in Kingston, Ontario, Canada.[1][3][4] He is a certified public accountant, and he speaks French, German and English.[1][3][4]

Career

Viehbacher started his career at PriceWaterhouseCoopers.[1][3][4] In 1988, he joined GlaxoSmithKline, where he worked for the next twenty years, including in France for ten years.[1][3] Until October 29, 2014, he served as CEO of Sanofi and Chairman of Genzyme.[3][4] Viehbacher has been Managing Partner of US-based healthcare investment fund Gurnet Point Capital since 2015.[7]

Viehbacher was Chairman of the Pharmaceutical Research and Manufacturers of America from December 2010 to April 2012.[2][3][4] He has been Chair of the CEO Roundtable on Cancer since February 2011.[3][4] He is a member of The Business Roundtable and the International Business Council.[3] He sits on the Board of Directors of Research America and the Burroughs Wellcome Fund.[2] He will serve as President of the European Federation of Pharmaceutical Industries and Associations from June 2013 onwards.[2][3]

In 2003, Viehbacher became a Knight in the Legion of Honour.[3] In 2012, he received the Pasteur Foundation Award.[3] He sits on the Board of Visitors of the Fuqua School of Business at Duke University.[3]

Personal life

Viehbacher is married and has three children, including a son.[4]

References

  1. 1 2 3 4 5 Christopher Viehbacher: Executive Profile & Biography - Businessweek
  2. 1 2 3 4 5 Christopher Viehbacher - Forbes
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 "Archived copy". Archived from the original on October 29, 2014. Retrieved October 29, 2014. Sanofi
  4. 1 2 3 4 5 6 7 8 9 10 Christopher A. Viehbacher | CEO Roundtable on Cancer
  5. ↑ "Ex-Sanofi CEO talks about his new $2 billion investment fund". Retrieved 2017-09-13.
  6. ↑ "Gurnet Point Capital nears deal to acquire drugmaker Innocoll: sources". Reuters. April 4, 2017. Retrieved 2017-09-13.
  7. ↑ "Subscribe to read". Financial Times. Retrieved 2017-11-17.
Business positions
Preceded by
Gérard Le Fur		 CEO of Sanofi
2008–2014		 Succeeded by
Olivier Brandicourt
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.